高级检索
当前位置: 首页 > 详情页

Risk factors predicting severe hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of General Surgery, China-Japan Friendship Hospital, Beijing, China [2]Digital Plastic Center of Plastic Surgery Hospital, Chinese Academy of Medical Sciences, Beijing, China [3]Department of Nephrology, China-Japan Friendship Hospital, Beijing, China
出处:
ISSN:

关键词: Severe hypocalcemia parathyroidectomy autotransplantation secondary hyperparathyroidism alkaline phosphatase risk factors

摘要:
Objective: This study was performed to investigate the risk factors for severe hypocalcemia (SH) after total parathyroidectomy without autotransplantation (TPTX) in patients with secondary hyperparathyroidism. Methods: We retrospectively analyzed the records of 136 patients with secondary hyperparathyroidism treated by TPTX. The patients were categorized as having SH or non-SH based on their postoperative blood calcium concentration. The risk factors for SH were identified by comparing the clinical characteristics between the two groups and by performing multiple logistic regression analyses. Results: After surgery, 46.0% of the patients had hypocalcemia and 31.7% had SH. Evidence of renal osteodystrophy on lumbar radiographs and the serum concentrations of intact parathyroid hormone (iPTH), calcium, and alkaline phosphatase (ALP) were different between the two groups. The SH group had higher preoperative iPTH and ALP concentrations than the non-SH group. In addition, more patients with SH showed renal osteodystrophy. Logistic regression analyses indicated that preoperative hypocalcemia and a high ALP concentration were independent predictors of SH. Conclusion: Preoperative hypocalcemia and a high ALP concentration were identified as risk factors for SH following TPTX.

语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2018]版:
Q4 PHARMACOLOGY & PHARMACY Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2018版] 出版当年五年平均[2014-2018] 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Department of General Surgery, China-Japan Friendship Hospital, Beijing, China
通讯作者:
通讯机构: [1]Department of General Surgery, China-Japan Friendship Hospital, Beijing, China [*1]Department of General Surgery, China-Japan Friendship Hospital, 2 Yinghuayuan Dongjie, Beijing 100029, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:817 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)